Congress trades in Chugai Pharmaceutical Co. (CHGCY)
Healthcare · Drug Manufacturers - General
2 members of Congress have disclosed 4 trades in Chugai Pharmaceutical Co. (CHGCY) since 2023: 0 buys and 4 sales. The most recent was disclosed on May 14, 2025.
- Trades disclosed
- 4
- Members trading
- 2
- Buys / sells
- 0 / 4
- Reported value
- $4K–$60K
Who traded CHGCY
- Rep. Josh Gottheimer (D-NJ-5)0 buys · 3 sales03May 14, 2025
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
All trades
- May 14, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Chugai Pharmaceutical Co. CHGCY
$1K–$15K · Traded Apr 9, 2025 · disclosed May 14, 2025 · Joint
- Jul 9, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Chugai Pharmaceutical Co. CHGCY
$1K–$15K · Traded Jun 21, 2024 · disclosed Jul 9, 2024 · Joint
- May 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Chugai Pharmaceutical Co. CHGCY
$1K–$15K · Traded Apr 4, 2024 · disclosed May 15, 2024 · Joint
- Aug 13, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold (full) Chugai Pharmaceutical Co. CHGCY
$1K–$15K · Traded Jul 10, 2023 · disclosed Aug 13, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.